D-Aspartate: An atypical amino acid with neuromodulatory activity in mammals

Reviews in the Neurosciences

Volumn 20, Issue 5-6, 2009, Pages 429-440

  Errico, Francesco ^a   Napolitano, Francesco ^a   Nisticò, Robert ^b,c   Centonze, Diego ^b,d   Usiello, Alessandro ^a,e  

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF CALABRIA   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e UNIVERSITY OF MOLISE   (Italy)

Author keywords

D amino acids; Hippocampus; NMDAR; Schizophrenia; Sensorimotor gating; Spatial memory; Striatum; Synaptic plasticity

Indexed keywords

AMINO ACID; AMPHETAMINE; DEXTRO ASPARTIC ACID; DIZOCILPINE; GLUTAMATE RECEPTOR; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

BRAIN; BRAIN DEVELOPMENT; CELL FATE; CELL MIGRATION; EMBRYO DEVELOPMENT; ENDOCRINE GLAND; ENZYME METABOLISM; GENE DELETION; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL PLASTICITY; NERVE FUNCTION; NEUROBLAST; NEUROMODULATION; NONHUMAN; PERINATAL PERIOD; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; REVIEW; SENSORIMOTOR CORTEX; SPATIAL MEMORY;

EID: 77950619696     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.2009.20.5-6.429     Document Type: Review

References (79)

1. Adachi M, Koyama H, Long Z, Sekine M, Furuchi T, Imai K, Nimura N, Shimamoto K, Nakajima T, Homma H. L-Glutamate in the extracellular space regulates endogenous D-aspartate homeostasis in rat pheochromocytoma MPTl cells. Arch Biochem Biophys 2004; 424: 89-96.
2. Anderson CM, Bridges RJ, Chamberlin AR, Shimamoto K, Yasuda-Kamatani Y, Swanson RA. Differing effects of substrate and non-substrate transport -inhibitors on glutamate uptake reversal. J Neurochem 2001; 79: 1207-1216.
3. Bak LK, Schousboe A, Waagepetersen HS. Characterization of depolarization-coupled release of glutamate from cultured mouse cerebellar granule cells using DL-threo-beta-benzyloxyaspartate (DL-TBOA) to distinguish between the vesicular and cytoplasmic pools. Neurochem Int 2003; 43: 417-424.
4. Barnes CA. Long-term potentiation and the ageing brain. Philos Trans Roy Soc Lond 2003; 358: 765-772.
5. Bendikov I, Nadri C, Amar S, Panizzutti R, De Miranda J, Wolosker H, Agam G. A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia. Schizophr Res 2007; 90: 41-51.
6. Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 2001; 156: 234-258.
7. Centonze D, Rossi S, Tortiglione A, Picconi B, Prosperetti C, De Chiara V, Bemardi G, Calabresi P. Synaptic plasticity during recovery from permanent occlusion of the middle cerebral artery, Neurobiol Dis 2007; 27: 44-53.
8. Centonze D, Usiello A, Costa C, Picconi B, Erbs E, Bemardi G, Borrelli E, Calabresi P. Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. J Neurosci 2004; 24: 8214-8222. (Pubitemid 39280800)
9. Corrigan JJ. D-Amino acids in animals. Science 1969; 164: 142-149.
10. Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, Hitzemann RJ, Maxson SC, Miner LL, Silva AJ, Wehner JM, Wynshaw-Boris A, Paylor R. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology 1997; 132: 107-124.
11. D'Aniello A. D-Aspartic acid: an endogenous amino acid with an important neuroendocrine role. Brain Res Rev 2007; 53: 215-234. (Pubitemid 46177230)
12. D'Aniello A, D'Onofrio G, Pischetola M, D'Aniello G, Vetere A, Petrucelli L, Fisher GH. Biological role of D-amino acid oxidase and D-aspartate oxidase. Effects of D-amino acids. J Biol Chem 1993; 268: 26941-26949. (Pubitemid 24006402)
13. D'Aniello A, Vetere A, Petrucelli L. Further study on the specificity of D-amino acid oxidase and D-aspartate oxidase and time course for complete oxidation of D-amino acids Comp Biochem Physiol 1993; 105: 731-734. (Pubitemid 23200130)
14. +-dependent "binding" of D-aspartate in brain membranes is largely due to uptake into membrane-bounded saccules. J Neurochem 1986; 47: 819-824.
15. Davies LP, Johnston GA. Uptake and release of D- and L-aspartate by rat brain slices. J Neurochem 1976; 26: 1007-1014.
16. Dunlop DS, Neidle A, McHaIe D, Dunlop DM, Lajtha A. The presence of free D-aspartic acid in rodents and man. Biochem Biophys Res Commun 1986; 141: 27-32. (Pubitemid 17002040)
17. Errico F, Nistico R, Palma G, Federici M, Affuso A, Brilli E, Topo E, Centonze D, Bemardi G, Bozzi Y, D'Aniello A, Di Laura R, Mercuri NB, Usiello A. Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility. Mol Cell Neurosci 2008; 37: 236-246. (Pubitemid 351173847)
18. Errico F, Pirro MT, Affuso A, Spinelli P, De Felice M, D'Aniello A, Di Lauro R. A physiological mechanism to regulate D-aspartic acid and NMDA levels in mammals revealed by D-aspartate oxidase deficient mice. Gene 2006; 374: 50-57. (Pubitemid 44240320)
19. Errico F, Rossi S, Napolitano F, Catuogno V, Topo E, Fisone G, D'Aniello A, Centonze D, Usiello A. D-Aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801. J Neurosci 2008; 28: 10404-10414.
20. Fagg GE, Matus A. Selective association of N-methyl aspartate and quisqualate types of L-glutamate receptor with brain postsynaptic densities Proc Natl Acad Sci USA 1984; 81: 6876-6880.
21. Fonnum F. Glutamate: a neurotransmitter in mammalian brain. J Neurochem 1984; 42: 1-11. (Pubitemid 14216942)
22. Fuchs SA, Berger R, Klomp LW, de Koning TJ. D-Amino acids in the central nervous system in health and disease. Mol Genet Metab 2005; 85: 168-180.
23. Fujii N. D-Amino acid in elderly tissues. Biol Pharm Bull 2005; 28: 1585-1589.
24. Fujii N. D-Amino acids in living higher organisms. Orig Life Evol Biosph 2002; 32: 103-127. (Pubitemid 34800938)
25. 3H]aspartate accumulation in mouse cerebellar slices. Brain Res 1985; 343: 129-136. (Pubitemid 16242904)
26. Gerlai R. LTP: variation between inbred mouse strains. Trends Neurosci 2001; 24: 75.
27. Grahn JA, Parkinson JA, Owen AM. The cognitive functions of the caudate nucleus Prog Neurobiol 2008; 86: 141-155.
28. Gundersen V, Danbolt NC, Ottersen OP, Storm-Mathisen J. Demonstration of glutamate/aspartate uptake activity in nerve endings by use of antibodies recognizing exogenous D-aspartate. Neuroscience 1993; 57: 97-111. (Pubitemid 23325637)
29. Hardingham GE, Bading H. The yin and yang of NMDA receptor signalling. Trends Neurosci 2003; 26: 81-89.
30. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10: 40-68; image 45.
31. Hashimoto A, Kumashiro S, Nishikawa T, Oka T, Takahashi K, Mito T, Takashima S, Doi N, Mizutani Y, Yamazaki T, et al. Embryonic development and postnatal changes in free D-aspartate and D-serine in the human prefrontal cortex. J Neurochem 1993; 61: 348-351.
32. Hashimoto A, Oka T. Free D-aspartate and D-serine in the mammalian brain and periphery. Prog Neurobiol 1997; 52: 325-353.
33. Hashimoto A, Oka T, Nishikawa T. Anatomical distribution and postnatal changes in endogenous free D-aspartate and D-serine in rat brain and periphery. Ew J Neurosci 1995; 7: 1657-1663.
34. Hashimoto K, Engberg G, Shimizu E, Nordin C, Lindstrom LH, Iyo M. Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 767-769.
35. Hashimoto K, Fujita Y, Horio M, Kunitachi S, Iyo M, Ferraris D, Tsukamoto T. Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine. Biol Psychiatry 2009; 65: 1103-1106.
36. Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N, Nakazato M, Kumakiri C, Okada S, Hasegawa H, Imai K, Iyo M. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry 2003; 60: 572-576.
37. 3H]aspartate transport by substance P in rat brain. Neurosci Lett 2000; 290: 113-116.
38. Heresco-Levy U, Javitt DC, Ebstein R, Vass A, Lichtenberg P, Bar G, Catinari S, Ermilov M. D-Serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biol Psychiatry 2005; 57: 577-585.
39. Homma H. Biochemistry of D-aspartate in mammalian cells. Amino Acids 2007; 32: 3-11.
40. Huang AS, Beigneux A, Weil ZM, Kim PM, Molliver ME, Blackshaw S, Nelson RJ, Young SG, Snyder SH. D-Aspartate regulates melanocortin formation and function: behavioral alterations in D-aspartate oxidase-deficient mice. J Neurosci 2006; 26: 2814-2819.
41. Javitt DC. Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatry2004; 9: 984-997, 979.
42. Kaindl AM, lkonomidou C. Glutamate antagonists are neurotoxins for the developing brain. Neurotox Res 2007; 11: 203-218.
43. Kanahara N, Shimizu E, Ohgake S, Fujita Y, Kohno M, Hashimoto T, Matsuzawa D, Shirayama Y, Hashimoto K, Iyo M. Glycine and D-serine, but not D-cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801. Psychopharmacology 2008; 198: 363-374.
44. Kera Y, Nagasaki H, Iwashima A, Yamada R. Gender dependence of D-aspartate oxidase activity in rat tissues. Comp Biochem Physiol 1993; 104: 739-742.
45. Koyama H, Adachi M, Sekine M, Katane M, Furuchi T, Homma H. Cytoplasmic localization and efflux of endogenous D-aspartate in pheochromocytoma 12 cells. Arch Biochem Biophys 2006; 446: 131-139.
46. Krebs HA. Metabolism of amino-acids: deamination of amino-acids. Biochem J 1935; 29: 1620-1644.
47. Kristiansen LV, Huerta I, Beneyto M, Meador-Woodruff JH. NMDA receptors and schizophrenia. Curr Opin Pharmacol 2007; 7: 48-55.
48. 2+ channels. J Neurochem 2009; 109: 168-181.
49. Martineau M, Baux G, Mothet JP. D-Serine signalling in the brain: friend and foe. Trends Neurosci 2006; 29: 481-491.
50. 3H]-glutamate recognition site in synaptic plasma membranes. J Neurochem 1987; 48: 1699-1708.
51. Morris RG, Anderson E, Lynch GS, Baudry M. Selective impairment of learning and blockade of longterm potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 1986; 319: 774-776.
52. Morris RG, Moser EI, Riedel G, Martin SJ, Sandin J, Day M, O'Carroll C. Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory. Philos Trans Roy Soc Lond 2003; 358: 773-786.
53. 3H]D-aspartate outflow from various in vitro preparations of the rat hippocampus. Neurochem Int 1997; 31: 113-124.
54. 2+-dependent pathway in a subset of rat pheochromo-cytoma PC12 cells. J Biol Chem 2001; 276: 26589-26596.
55. Negri A, Ceciliani F, Tedeschi G, Simonie T, Ronchi S. The primary structure of the flavoprotein D-aspartate oxidase from beef kidney. J Biol Chem 1992; 267: 11865-11871.
56. Neidle A, Dunlop DS. Developmental changes in free D-aspartic acid in the chicken embryo and in the neonatal rat. Life Sci 1990; 46: 1517-1522.
57. Nguyen PV, Gerlai R. Behavioural and physiological characterization of inbred mouse strains: prospects for elucidating the molecular mechanisms of mammalian learning and memory. Genes Brain Behav 2002; 1: 72-81.
58. 3H] glutamate binding sites in brain synaptic membranes. Biochem Biophys Res Commun 1988; 153: 510-517.
59. 3H]D-2-amino-5-phosphonopentanoic acid binding in rat brain membranes. Neuroscience 1988; 26: 17-31.
60. Palacin M, Estevez R, Bertran J, Zorzano A. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev 1998; 78: 969-1054.
61. Pisani A, Centonze D, Bemardi G, Calabresi P. Striatal synaptic plasticity: implications for motor learning and Parkinson's disease. Mov Disord 2005; 20: 395-402. (Pubitemid 40779013)
62. 3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines. J Neurochem 1988; 51: 830-836.
63. Sakai K, Horama H, Lee JA, Fukushima T, Santa T, Tashiro K, Iwatsubo T, Imai K. Emergence of D-aspartic acid in the differentiating neurons of the rat central nervous system. Brain Res 1998; 808: 65-71.
64. Saransaari P, Oja SS. Mechanisms of D-aspartate release under ischemic conditions in mouse hippocampal slices. Neurochem Res 1999; 24: 1009-1016.
65. Saransaari P, Oja SS. Regulation of D-aspartate release by glutamate and GABA receptors in cerebral cortical slices from developing and ageing mice. Neuroscience 1994;,60: 191-198. (Pubitemid 124016671)
66. 3H]-D-aspartate release from hippocampal slices. Neurochem Int 2001; 38: 255-267.
67. Schell MJ, Cooper OB, Snyder SH. D-Aspartate localizations imply neuronal and neuroendocrine roles. Proc Natl Acad Sci USA 1997; 94: 2013-2018.
68. Snyder SH, Kim PM. D-Amino acids as putative neurotransmitters: focus on D-serine. Neurochem Res 2000; 25: 553-560.
69. Still JL, Buell MV, et al. Studies on the cyclophorase system; D-aspartic oxidase. J Biol Chem 1949; 179: 831-837.
70. Takagaki G. Sodium and potassium ions and accumulation of labelled D-aspartate and GABA in crude synaptosomal fraction from rat cerebral cortex. J Neurochem 1978; 30: 47-56. (Pubitemid 8266274)
71. Tsai G, Coyle JT. Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol 2002; 42: 165-179.
72. Tsai G, Yang P, Chung LC, Lange N, Coyle JT. D-Serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 1998; 44: 1081-1089.
73. Tsai GE, Yang P, Chung LC, Tsai IC, Tsai CW, Coyle JT. D-Serine added to clozapine for the treatment of schizophrenia. Am J Psychiatry 1999; 156: 1822-1825. (Pubitemid 29517581)
74. Van Veldhoven PP, Brees C, Mannaerts GP. D-Aspartate oxidase, a peroxisomal enzyme in liver of rat and man. Biochim Biophys Acta 1991; 1073: 203-208.
75. Wang H, Wolosker H, Morris JF, Pevsner J, Snyder SH, Selkoe DJ. Naturally occurring free D-aspartate is a nuclear component of cells in the mammalian hypothalamo-neurohypophyseal system. Neuroscience 2002; 109: 1-4. (Pubitemid 34088142)
76. Weil ZM, Huang AS, Beigneux A, Kim PM, Molliver ME, Blackshaw S, Young SG, Nelson RJ, Snyder SH. Behavioural alterations in male mice lacking the gene for D-aspartate oxidase. Behav Brain Res 2006; 171: 295-302. (Pubitemid 43946504)
77. Wolosker H, D'Aniello A, Snyder SH. D-Aspartate disposition in neuronal and endocrine tissues: ontogeny, biosynthesis and release. Neuroscience 2000; 100: 183-189. (Pubitemid 30670311)
78. Yang H, Zheng G, Peng X, Qiang B, Yuan J. D-Amino acids and D-Tyr-tRNA(Tyr) deacylase: stereospecificity of the translation machine revisited. FEBS Lett 2003; 552: 95-98. (Pubitemid 37186841)
79. Zaar K, Kost HP, Schad A, Volkl A, Baumgart E, Fahimi HD. Cellular and subcellular distribution of D-aspartate oxidase in human and rat brain. J Comp Neurol 2002; 450: 272-282. (Pubitemid 34809997)